NDT Pharmaceuticals Inc.
NDTP · OTC
12/31/2024 | 12/31/2023 | 12/31/2017 | 12/31/2016 | |
|---|---|---|---|---|
| Market Cap | $8,480 | $9,800 | $30 | $30 |
| - Cash | $0 | $1 | $0 | $0 |
| + Debt | $0 | $0 | $350 | $350 |
| Enterprise Value | $8,480 | $9,800 | $380 | $380 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$17 | $89 | -$1 | -$2 |
| % Margin | – | – | – | – |
| Net Income | -$17 | -$79 | -$1 | -$2 |
| % Margin | – | – | – | – |
| EPS Diluted | -0 | -0.001 | -0.004 | -0.006 |
| % Growth | 80% | 87.8% | 35.9% | – |
| Operating Cash Flow | – | -$18 | – | – |
| Capital Expenditures | – | $0 | – | – |
| Free Cash Flow | – | -$18 | – | – |